This $1,650 pill will tell your doctors if you’ve taken it

Source: Christopher Rowland, Washington Post (Paid Registration)

When the Food and Drug Administration approved in late 2017 a schizophrenia pill that sends a signal to a patient’s doctor when ingested, it was seen not only as a major step forward for the disease but as a new frontier of Internet-connected medicine.

Seventeen months later, few patients use the medication, known as Abilify MyCite. Doctors and insurance companies say it is a case in which real-world limitations, as well as costs, outweigh the innovations that the medical industry can produce.

Read Full Article: This $1,650 pill will tell your doctors if you’ve taken it

 

Tags/Keywords

 

Search

Quick Menu

Facebook FTwitter T
 

Consumer Help Desk

Advocacy